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Abstract The purinergic rP2X7 receptor expressed in a number
of heterologous systems not only functions as a cation channel
but also gives rise to a P2Z-like response, i.e. a reversible
membrane permeabilization that allows the passage of molecules
with molecular masses of v 300 Da. We investigated the
properties of rP2X7 receptors expressed in Xenopus oocytes.
In two-electrode voltage-clamp experiments, ATP or BzATP
caused inward currents that were abolished or greatly diminished
when NMDG

or choline

replaced Na

as the principal
external cation. In fluorescent dye experiments, BzATP
application did not result in entry of the fluorophore YO-PRO-
1
2
. Thus, rP2X7 expression in Xenopus oocytes does not by
itself give rise to the pore-forming P2Z phenotype, suggesting
that ancillary factors are involved.
z 1997 Federation of European Biochemical Societies.
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1. Introduction
ATP can serve as an extracellular ligand for three classes of
receptors which are designated P2X, P2Y and P2Z. P2Y re-
ceptors are G-protein-coupled membrane proteins; P2X re-
ceptors are ion channels that are permeable to cations; and
P2Z receptors, when activated, permeabilize cells to molecules
as large as 900 Da [1]. Thus, activation of P2Z receptors
appears to result in the generation of large pores in the plas-
ma membrane. P2Z receptors have attracted considerable at-
tention since they are expressed in macrophages and lympho-
cytes where they may play a role in signaling between cells or
in the interaction of these immune cells with their targets [2].
Recently evidence has been o¡ered that the P2Z receptor is
actually one member of the P2X class, seven di¡erent mem-
bers of which have now been cloned [2,3]. The most recently
cloned of these, rP2X7 (P2X7 from the rat Rattus norvegicus)
functions as a cation channel at normal concentrations of
divalent cations. But its activation by ATP or BzATP in the
presence of submillimolar concentrations of external divalent
cations results in permeability for larger molecules like
NMDG

(195 Da) or the dye YO-PRO-1
2
(376 Da). This
pore forming e¡ect was demonstrated in a variety of cultured
cells transfected with the rP2X7 receptor [3].
To investigate in more detail the ability of rP2X7 receptors
to induce permeability to larger molecules, we decided to use
the Xenopus oocyte expression system. We did so because of
earlier studies on mouse macrophages which have been shown
to have a P2Z-like pore-forming response. When poly(A)

RNA from mouse macrophages is injected into Xenopus oo-
cytes, ATP application in the presence of submillimolar con-
centrations of external divalent cations causes the oocytes to
become permeable to NMDG

and large molecular weight
dyes [4]. We decided to repeat these observations by injecting
rP2X7 cRNA into the oocytes. Unexpectedly, ATP or BzATP
application to these cells did not result in permeabilization of
the cells to large molecular weight compounds. This conclu-
sion was reached on the basis of two separate lines of exper-
imentation, electrophysiological monitoring of ionic currents
under voltage-clamp and £uorescence measurements of dye
entry. Thus it would appear that ATP-induced permeabiliza-
tion (i.e. pore formation) depends on factors in addition to the
rP2X7 receptor itself.
2. Materials and methods
2.1. In vitro transcription and plasmid preparation
Plasmid cDNA encoding the rat rP2X7 receptor (GenBank acces-
sion number X95882) was kindly supplied by Dr. Gary Buell (Glaxo
Institute for Molecular Biology, Switzerland). Plasmids were prepared
by standard procedures and puri¢ed using a Plasmid Maxi kit (Qiagen
Inc. Chatsworth, CA). Restriction mapping and partial sequencing
were performed to verify that the cDNA in our plasmid was that of
the sequence published for rP2X7 receptor. Plasmids were linearized
in preparation for transcription run-o¡ using the XhoI restriction site.
In vitro transcription was performed using a mMessage mMachine kit
(Ambion Inc. Austin, TX). The only departure from the manufactur-
er's protocol was that, following DNAase treatment, the full-length,
capped cRNA was puri¢ed using Chroma Spin 100 columns equili-
brated with DEPC-treated water (Clontech, Palo Alto, CA). cRNA
samples were run on a denaturing agarose RNA gel and were used
only if they were of the expected size and ran as a single band.
2.2. Oocyte preparation and cRNA injection
Oocytes were isolated from Xenopus laevis (supplied by Nasco, Fort
Atkinison, WI, and Xenopus 1, Dexter, MI) using standard protocols
[5] and scored according to Dumont [6]. Only stage V or VI defollic-
ulated oocytes were used. cRNA was used at a 1 Wg/ml concentration
in DEPC-treated water and 25^50 ng injected into each oocyte using a
Drummond `Nanoject' motorized microinjection device (Drummond
Scienti¢c Co., Broomal, PA) Sham-injected oocytes were injected with
the appropriate amount of DEPC-treated water alone. Oocytes were
then incubated in Barth's solution with gentamicin (50 mg/ml; Sigma)
and penicillin streptomycin (100 U/ml; Sigma) at 18³C and used from
2 to 5 days following injection. To diminish the e¡ects of Ca
2
-acti-
vated Cl
3
currents endogenous to Xenopus oocytes, the oocytes were
injected with 40^50 nl of a 50 mM EGTA or BAPTA solution (¢nal
concentrationV1 mM) into oocytes 30 min prior to experimentation.
Such protocols have been used in the past to successfully inhibit these
contaminating currents [7]. In some experiments no BAPTA or EGTA
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injection was carried out. All experiments were performed at room
temperature (20^23³C).
2.3. Electrophysiology
Standard two-electrode voltage clamp techniques [8] were used to
investigate rP2X7 receptor responses in oocytes. A Dagan TEV-200
two-electrode voltage-clamp ampli¢er and pClamp 6 software were
used for control of experimental protocols and data conditioning
and acquisition. For most experiments oocytes were held at a mem-
brane potential of 350 mV. Voltage ramps were used to investigate
current^voltage relationships. The potential was ¢rst moved from the
holding level of 350 to 380 mV then moved gradually to +20 mV
(voltage ramp rate 12.5 mV/s) and ¢nally back to the holding level.
When leak subtraction was employed, currents obtained by ramps
performed under control conditions were subtracted from currents
under test conditions. Microelectrodes were ¢lled with a 3 M KCl
solution ¢ltered with a sterile Millex-GV 0.22 Wm ¢lter unit (Millipore
Bedford, MA). Electrode resistance for the voltage electrode ranged
from 2^5 M6, and for the current passing electrode resistance was
typically 1 M6. Concentration^response curves were ¢t to logistic
functions using a Marquardt-Levenberg algorithm as implemented
in a commercial software package (SigmaPlot; Jandel Corporation,
CA)
2.4. Solutions and drugs
The £ow of the extracellular bathing solution was controlled using
a DAD-12 computerized perfusion device (Adams and List, NY)
coupled to a multipath manifold located at the entry portal to the
bath chamber. This arrangement enabled fairly rapid changes in bath-
ing solution in the 150 Wl chamber. Five to 10 s were required to
completely exchange the bathing solution in the chamber. Thus, the
solution surrounding the oocyte which was located at the mouth of
the manifold outlet was exchanged even more rapidly. For most ex-
periments a bathing solution low in divalent cation concentration was
used which contained (in mM) Na

96, K

2, Cl
3
98, HEPES 5, Ca
2
0.1, pH 7.5; Ba
2
at the same concentration (0.1) was sometimes
substituted for Ca
2
. In BAPTA- or EGTA-injected oocytes we could
see no di¡erence between recordings made in the presence of Ba
2
or
Ca
2
. In some experiments BAPTA or EGTA injection was not car-
ried out, but the general conclusions were the same in all cases. ATP
or BzATP were obtained from Sigma Chemicals (St. Louis, MO) and
were dissolved at working concentrations directly into bathing solu-
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Fig. 1. Comparison of ATP and BzATP activated currents. A: Application of ATP (300 WM; calculated free ATP
43
, 118 WM) to a BAPTA-
treated oocyte injected with rP2X7 cRNA reversibly activated a large inward current. B: In a di¡erent oocyte, application of BzATP (100 WM;
calculated free BzATP
43
, 35 WM) also activated an inward current. The ¢rst application of BzATP resulted in the largest current which is
shown in the trace at upper left. Smaller currents elicited by subsequent applications of BzATP at 12 min intervals are shown in the remaining
traces. Note that the scale is identical for the ¢rst trace and the subsequent traces which depict much smaller currents. The period of ATP or
BzATP application is shown by the horizontal bar beneath the current trace. Holding potential was 350 mV in each case.
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tion. ATP or BzATP were used at total ¢nal concentrations of 300
WM or 100 WM which gave calculated free concentrations of 118 WM
and 35 WM, respectively, in a 100 WM Ca
2
bathing solution [9].
(Unless otherwise speci¢ed, total concentration is given in the text.)
In making calculations for free [BzATP
43
], the same dissociation con-
stants were used as for ATP. Solutions containing NMDG (MW 196;
Fluka, Ronkonkoma, NY) or choline chloride (MW 140; Sigma),
were made by substituting these large organic cations for Na

and
K

. Staphylococcal alpha-toxin was obtained from Life Technologies
(Grand Island, NY) and Saponin from ICN Pharmaceuticals (Costa
Mesa, CA).
2.5. YO-PRO-1 entry
YO-PRO-1 (MW of the di-iodide salt=629; 1 mM stock in DMSO;
Molecular Probes, Eugene, OR) was dissolved into 10 ml of 0.1 mM
Ca
2
bathing solution and divided equally into two separate 35 mm
plastic petri dishes to give a ¢nal YO-PRO-1
2
concentration of 10
WM. To one of these dishes BzATP was added to a give a ¢nal total
concentration of 100 WM. Oocytes were placed in either dish for 5 min
and then returned to a dish containing 0.1 mM Ca
2
bath alone.
Fluorescence intensity of oocytes was monitored using a Nikon Dia-
phot £uorescence microscope equipped with a £uorescein isothiocya-
nate ¢lter set, a 20U objective and a digital camera (Photometrics,
Tuscon, AZ). 100 ms exposures were taken and stored on computer
disk for later analysis using custom software to de¢ne and measure
the average intensity of a 10U10 pixel region of interest. Fluorescence
intensity was plotted as the average number of photons detected in
this region during the 100 ms exposure and was designated as counts/
100 ms. Background £uorescence intensity was determined by making
measurements of oocytes that had never been incubated in YO-PRO-
1
2
. To ensure that oocytes used for these measurements were indeed
expressing functional rP2X7 receptors, we randomly chose ¢ve oo-
cytes from each batch and tested for appearance of BzATP-activated
currents using two electrode voltage clamp. For each batch tested, ¢ve
of ¢ve oocytes showed BzATP-activated currents, suggesting that ex-
pression e¤ciency was close to 100%. This was also our experience
with the oocytes during the electrophysiological experiments described
above.
In experiments utilizing HEK293 cells we assayed YO-PRO-1
2
uptake in cells cultured onto 12U12 mm glass coverslips. YO-PRO-
1 £uorescence intensity was measured using a Nikon Diaphot micro-
scope equipped with a 40U objective; both a bright¢eld and a £uo-
rescent image of the same microscope ¢eld were stored onto computer
disk for later analysis. To determine the percentage of cells that were
YO-PRO-1
2
positive, the total number of cells in the bright¢eld
image was counted manually. The number of cells that were £uores-
cent, indicating YO-PRO-1
2
entry, was then determined from the
corresponding £uorescent image.
3. Results
3.1. ATP or BzATP activates cationic currents in Xenopus
oocytes injected with cRNA encoding the rP2X7 receptor
Xenopus oocytes were either injected with cRNA for the
rP2X7 receptor or sham-injected with a similar volume of
DEPC-treated water. Application of ATP (300 WM; calcu-
lated free ATP
43
, 118 WM) or BzATP (100 WM; calculated
free BzATP
43
, 35 WM) in solutions containing a low concen-
tration of divalent cations (100 WM Ca
2
or Ba
2
) produced
no response in sham-injected oocytes (n=6) but yielded large
currents in oocytes injected with rP2X7 cRNA (Fig. 1.) The
currents reversed direction at a membrane potential of 310 to
320 mV (n=12), as expected for the cationic currents carried
by P2X channels.
When ATP was used, the current trace took about a minute
to return to baseline (Fig. 1A) upon termination of ATP ap-
plication. Repeated applications of ATP produced currents of
identical amplitude, given a su¤ciently long interval (20 min
or more) between applications.
When BzATP was applied (Fig. 1B), the resulting currents
were typically larger and desensitized more quickly than those
generated in response to ATP. Recovery also took longer, the
current trace often requiring 10 min or more to return to
baseline upon termination of BzATP application (n=9).
(Slow recovery of BzATP-activated current was also observed
in earlier work on HEK293 cells transfected with rP2X7
cDNA [3].) In most cases, repeated applications of BzATP
(1^30 s; 100 WM) at 10^12 min intervals produced currents
that were far smaller than the initial response (Fig. 1B), most
likely due to a long-lasting desensitization. Even when periods
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Fig. 2. ATP concentration^response relationship in oocytes expressing rP2X7 receptors. Peak inward current was measured in response to ap-
plications of ATP in three di¡erent BAPTA-injected oocytes. Data for each of the oocytes is shown ¢t with a logistic curve constrained to
0 and 100% at, respectively, the minimum and maximum response. Averaged, normalized values were also ¢t with a single logistic curve, yield-
ing an EC
50
of 10 WM (3.3 WM for calculated free ATP
43
) and a Hill coe¤cient of 1.7. Holding potential was 350 mV.
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of 1 h were allowed between applications of BzATP, full re-
covery did not always occur. However, in some cases repeated
applications of BzATP produced an increasing current which
desensitized very gradually (see below, Fig. 4A).
The concentration^response relationship for the rP2X7 re-
ceptors expressed in Xenopus oocytes was determined using
ATP (Fig. 2). Several measures were taken to avoid possible
distortions that might arise as a result of desensitization in
response to application of ATP. First, a minimum of 20 min
was allowed to elapse between successive applications of ATP
to permit recovery from desensitization. Second, for each oo-
cyte tested, the application of at least one concentration of
ATP was repeated during the course of the experiment to
ensure that responses to that concentration were unchanged
over time. The EC
50
derived from these relationships was
around 10 WM, almost an order of magnitude less than that
observed previously in HEK293 cells transfected with rP2X7
cDNA [3]. In terms of free ATP
43
which is thought to be the
ligand for P2X7 and P2Z receptors (but see Ugur et al. [10]),
the EC
50
was calculated to be 3.3 WM.
3.2. Ion substitution studies provide no evidence for induction of
large pores by BzATP
BzATP is the most potent agonist for activating both native
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Fig. 3. BzATP-activated inward currents are markedly decreased when NMDG

is substituted for extracellular Na

. A: Current trace showing
result of ¢rst application of BzATP to an oocyte injected with rP2X7 cRNA. BzATP application indicated by the bar below the trace lasted
for 30 s. (At `a' and `b' a voltage ramp was applied, i.e. the voltage was changed from the holding level of 350 to 380 mV, then moved grad-
ually to +20 mV at a rate of 12.5 mV/s and then back to the holding potential.) The oocyte was continuously superfused, so that BzATP was
washed away within a few seconds after application was terminated. When NMDG

-containing superfusate was substituted for the normal
Na

-containing superfusate, the BzATP-activated inward current was eliminated; upon restoration of normal superfusate, the BzATP-activated
inward current returned. B: BzATP was then applied at 12 min intervals after complete recovery from the BzATP-induced current shown in
(A). The ¢fth such application is shown here, the protocol being the same as in (A) with the same sort of voltage ramps applied at `c' and `d'.
The period of BzATP or NMDG application is shown by the horizontal bar beneath the current trace. C: Current^voltage curves obtained
from voltage ramps applied at `a' and `b' in (A). When NMDG

replaced Na

in the external solution, the reversal potential shifted from
V315 mV to V365 mV.
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P2Z receptors [2] and cloned rP2X7 receptors in a number of
cell types [3]. BzATP was applied to the Xenopus oocytes
injected with rP2X7 cRNA, and the resulting currents in sol-
utions containing Na

were compared to those in solutions
containing the larger organic cations, NMDG

(MW 195) or
choline

(MW 104). Voltage ramps were applied to obtain
measures of conductance and reversal potential. Following
the exchange of Na

for NMDG

, the BzATP-activated in-
ward current decreased dramatically (Fig. 3A,B) and reversal
potentials shifted to a more negative value (Fig. 3C). On
average the reversal levels shifted from 312þ 1.9 mV to
360þ 3.1 mV (n=5). When choline

was substituted for
Na

the reversals shifted from 36.3 þ 4.4 to 327þ 2.5 mV
(n=3). Thus, NMDG

and choline

were far less e¡ective
current carriers than Na

, a result inconsistent with the pres-
ence of a large pore. (A P
NMDG
/P
Na
ratio of 0.15þ 0.01 (n=5)
could be calculated for the rP2X7 receptor from the shift in
reversal potential and a P
choline
/P
Na
ratio of 0.44þ 0.04 (n=3)
could be calculated in the same way. Such calculations, how-
ever, are based on the assumption that current carried by
other external ions is negligible.)
Repeated applications of BzATP most often produced the
type of responses shown in Fig. 3A,B where the responses
grew smaller with repeated applications. In a few oocytes
(n=4) repeated applications of BzATP resulted in a current
which slowly grew to a maximum and then desensitized very
gradually (Fig. 4A.) In such cases superfusion with NMDG

-
containing solution in place of Na

-containing solutions pro-
duced a large negative shift in the reversal potential (Fig. 4B).
This is inconsistent with the presence of large pores readily
permeable to NMDG

.
In several experiments (n=9) the oocytes were injected with
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Fig. 4. NMDG

does not readily permeate those oocytes that have longer lasting rP2X7 responses. A: Thirteen successive 2-s pulses of BzATP
(shown as ticks beneath the trace) induced a current that did not desensitize until after many hundreds of seconds. Between applications of
BzATP the oocyte was continuously superfused with normal bathing solution. NMDG

-containing superfusate replaced the normal Na

-con-
taining superfusate as indicated. Inward current is greatly diminished in the presence of NMDG

. Voltage ramps of the same type as those
shown in Fig. 3 were applied at `a' through `e'. B: Current^voltage plots obtained from ramps `a' through `e'. In the presence of NMDG

the
reversal level shifts more than 30 mV in the negative direction, as expected for a greatly decreased permeability to NMDG

in comparison to
inorganic cations.
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EGTA. We could ¢nd no di¡erence in the BzATP-induced
currents in oocytes injected with BAPTA compared to those
injected with EGTA. A number of experiments were also per-
formed in extracellular solutions containing either zero Ca
2
(5 mM EGTA and no added Ca
2
; n=3) or 300 WM Ca
2
(n=3). Under these conditions BzATP-induced currents were
the same as those recorded with 100 WM Ca
2
in the extra-
cellular solution.
3.3. Fluorescent dye measurements provide no evidence for
induction of pores by BzATP
Previous studies have used the entry of the £uorescent
monomeric cyanine dye YO-PRO-1 di-iodide (MW of the
cyanine cation: 376) as a marker for `pore' formation induced
by activation of native P2Z receptors or the cloned rP2X7
receptor [3]. Upon entry into a cell YO-PRO-1
2
binds tightly
to nucleic acids which increases its emission intensity and thus
allows it to act as an indicator of cumulative entry. To test for
YO-PRO-1
2
permeation, Xenopus oocytes were bathed either
in a solution containing YO-PRO-1
2
(10 WM) alone or a
solution containing both YO-PRO-1
2
(10 WM) and BzATP
(100 WM; free BzATP
43
, 35 WM). In each case the solution
was nominally Mg
2
-free and contained 100 WM Ca
2
. The
£uorescence intensity of sham-injected oocytes and oocytes
injected with rP2X7 cRNA was compared after 5 min using
a digital imaging microscope. As shown in Fig. 5A, there was
no indication that BzATP could increase the entry of YO-
PRO-1
2
into rP2X7 cRNA injected oocytes. Even after 20
min (data not shown) there was no indication of BzATP-in-
duced YO-PRO-1
2
entry in the oocytes expressing the rP2X7
receptors. For the experiments performed on oocytes, positive
controls employed the membrane-spanning, pore-producing
Staphylococcal alpha-toxin, which creates pores that permit
entry of molecules up to 3 kDa [11], or the membrane per-
meabilizing agent saponin [10]. In the presence of these agents
(Fig. 5A), YO-PRO-1
2
entry into the oocytes could be moni-
tored readily.
When similar experiments were performed with HEK293
cells stably transfected with rP2X7 (kindly supplied by George
Dubyak), BzATP-activated YO-PRO-1
2
entry was clearly
present (Fig. 5B), con¢rming the earlier observation that in
HEK293 cells BzATP induces a non-selective pathway perme-
able to YO-PRO-1
2
[3].
In summary, two independent lines of experimentation,
electrophysiological analyses of ion currents and £uorescent
measurements of YO-PRO-1
2
dye entry, failed to disclose
evidence of pore formation in Xenopus oocytes expressing
cloned rP2X7 receptors.
4. Discussion
With the cloning and characterization of the rP2X7 recep-
tor by Surprenant et al. [3], two long-standing lines of inves-
tigation converged. The ¢rst stems from the hypothesis orig-
inally put forward by Burnstock [12] that ATP acts as a
neurotransmitter which activates ligand-gated cation channels
that came to be known as P2X receptors. The second line of
study arises from the observation of Cockroft and Gomperts
[13,14] that mast cells could be reversibly permeabilized to
molecules much larger than organic cations by ATP
43
, the
receptors for which are designated as P2Z receptors. Surpren-
ant et al. [3] have now shown that a variety of cells transfected
with rP2X7 cDNA can give rise to P2Z-like or `pore-forming'
responses when treated with ATP or BzATP, an observation
that we have con¢rmed in this report. The results in the
present study suggest that factors in addition to the rP2X7
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Fig. 5. Failure of oocytes injected with rP2X7 cRNA to accumulate YO-PRO-1
2
in response to BzATP application. A: Entry of YO-PRO-
1
2
into oocytes was monitored by measuring average £uorescence intensity of a region of the oocyte. `No YO-PRO-1' represents pooled aver-
age of sham-injected oocytes and oocytes injected with rP2X7 cRNA in the absence of YO-PRO-1
2
. `Sham, 5P' represents £uorescence of
sham-injected oocytes after 5 min in YO-PRO-1
2
solution without BzATP. `Sham+BzATP 5P' represents another group of sham-injected oo-
cytes after 5 min in a solution containing both YO-PRO-1
2
and BzATP. `rP2X7, 5P' and `rP2X7+BzATP, 5P' give results for oocytes injected
with rP2X7 cRNA. BzATP treatment did not increase the measured YO-PRO-1
2
entry in the oocytes expressing the rP2X7 receptors. In con-
trast treatment with Staphylococcal alpha-toxin (250 U/ml for 5 min) or saponin (100 Wg/ml for 3 min) produced a signi¢cant increase in £uo-
rescence intensity when YO-PRO-1
2
was present. Graph shows average and SEM for each treatment group. The number in parenthesis indi-
cates the number of oocytes that were used for each observation. B: In HEK293 cells BzATP treatment induces YO-PRO-1
2
entry. Summary
of results from HEK293 cells stably expressing rP2X7 receptors (`P2X7') compared to untransfected controls (`untransfected'). `-BzATP' indi-
cates those cells that were exposed to YO-PRO-1
2
(10 WM) alone for 3 min and `+BzATP' indicates those cells exposed to YO-PRO-1
2
with
BzATP (100 WM) for 3 min. In each case the percentage of cells showing YO-PRO-1
2
£uorescence per microscope ¢eld (typically 100 cells or
more) was determined, and the results from several di¡erent coverslips (number of coverslips shown in parentheses) were averaged and plotted
with SEM. Data were compared with multiple t-tests using Bonferroni adjustment (GBSTAT vers. 6.0, Dynamic Microsystems Inc.) of K-values
for multiple planned comparisons.

Group is signi¢cantly di¡erent from other groups (P6 0.05).
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receptor are involved in the pore-forming response since Xen-
opus oocytes injected with rP2X7 cRNA express ATP-gated
cation channels but not larger pores of the P2Z type.
What could the additional factor or factors be? Our origi-
nal hypothesis was that the P2X4 subtype, when co-expressed
with P2X7, might form a complex which would inhibit the
formation of larger pores. This idea arose from our work on a
P2X receptor in smooth muscle cells from toad stomach
which gave rise to cationic currents and which had a pharma-
cological pro¢le resembling P2Z receptors in many respects
[10]. However, this receptor did not give rise to larger pores.
Although this receptor from toad has not been cloned, a sim-
ilar response was observed some time ago by Honore et al.
[15] in pregnant rat myometrial cells. Poly(A)

RNA which
we prepared from such myometrial cells was analyzed using
PCR by Buell and his colleagues, and both P2X4 and P2X7
subtypes were found (unpublished observations). Moreover,
Juranka et al. [16] recently screened a Xenopus oocyte
cDNA library and found ¢ve cDNAs, designated xP2X4a-e,
with a 67% predicted amino acid identity to rat P2X4 recep-
tors. It is possible that one of these xP2X4 subunits serves to
inhibit the formation of P2Z-like receptors from the P2X7
subtype, perhaps by forming a heterooligomer.
However, there is reason to believe that a factor other than
the P2X4 subtype, or in addition to it, is at work. Nuttle and
Dubyak [4] have studied P2Z responses in the murine macro-
phage cell line BAC1.2F5 which has P2X7 mRNA (Dubyak,
personal communication). When Xenopus oocytes are injected
with poly(A)

RNA derived from the murine BAC1.2F5 cells,
P2Z-like responses are seen. These results combined with the
results in the present study suggest that there is a factor coded
for by the BAC1.2F5 murine macrophage mRNA which is
necessary for the P2Z response, i.e. a facilitatory as opposed
to an inhibitory agent.
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